In vitro and in vivo anti-Helicobacter/Campylobacter activity of the aqueous extract of Enantia chlorantha

Pharmaceutical Biology
P V TanFrançois-Xavier Etoa

Abstract

The aqueous extract of Enantia chlorantha Oliver (Annonaceae) stem bark, a plant widely used in Cameroon for the traditional treatment of gastritis and stomach problems, was assessed for in vitro and in vivo anti-Helicobacter/Campylobacter properties using the well diffusion assay, agar dilution assay, and killing rate determination. The in vitro activity was dose-dependent, and the same antimicrobial parameters (MAQ = 0.63 mg; MIC = 0.39 mg/mL; MBC = 1.56 mg/mL; ET(100) = 8 h) were obtained for both H. pylori and C. jejuni/coli. When the plasma active principle concentration equivalence was determined in vitro using plasma from rats exposed to a single dose (3000 mg/kg) of the extract, the peak absorption of E. chlorantha active principle against H. pylori occurred at 2 h. Plasma activity was nil 8 h after extract administration. The in vivo H. pylori eradication potency of the extract was assessed using mice infected with H. pylori. Antral mucus sample cultures from mice treated with E. chlorantha extract (500 and 1000 mg/kg for 3 days) did not yield any growth. The results suggest that in addition to its in vitro activity, E. chlorantha water extract also possesses in vivo antibiotic effects against H. pylori.

References

Oct 1, 1993·The American Journal of Tropical Medicine and Hygiene·B M Kotecka, K H Rieckmann
Oct 23, 1997·Clinical Microbiology Reviews·B E DunnM J Blaser
May 30, 1998·British Medical Bulletin·F Mégraud
May 29, 1999·Antimicrobial Agents and Chemotherapy·I J HassanM R Millar
Feb 28, 2002·Alimentary Pharmacology & Therapeutics·P MalfertheinerUNKNOWN European Helicobacter Pylori Study Group (EHPSG)
Dec 4, 2002·The Journal of Antimicrobial Chemotherapy·Takeshi OkamotoMutsunori Shirai
Dec 4, 2002·The Journal of Antimicrobial Chemotherapy·Tamara Matysiak-BudnikFrancis Mégraud
Feb 1, 2006·Nature Clinical Practice. Cardiovascular Medicine·Christina M WyattJonathan A Winston

❮ Previous
Next ❯

Citations

Apr 1, 2014·The Journal of Microbiology·Morris O MakobongoD Scott Merrell
Jun 9, 2020·Evidence-based Complementary and Alternative Medicine : ECAM·Delfina Fernandes HlashwayoCustódio Gabriel Bila
Jan 23, 2020·Mini Reviews in Medicinal Chemistry·Iraj SalimikiaMohammad Reza Nazer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.